TechNavio's analysts forecast the OTC Pharmaceuticals Market in the APAC region to grow at a CAGR of 3.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals market in the APAC region has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the product recalls by the US FDA could pose a challenge to the growth of this market.
TechNavio's report, the OTC Pharmaceuticals Market in the APAC Region 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report focuses on the APAC region; it also covers the OTC Pharmaceuticals market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Johnson & Johnson, GlaxoSmithKline plc, Novartis International AG, and Bayer Healthcare AG.
The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH, Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., and Schering-Plough Corp., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. Introduction
03. Market Coverage
Business Overview
Product Offerings
04. Market Landscape
04.1 Market Size and Forecast
04.2 Market Segmentation
04.3 Five Forces Analysis
05. Key Leading Countries
Japan
China
India
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Johnson & Johnson
Business Overview
Key Information
SWOT Analysis
13.2 GlaxoSmithKline plc
Business Overview
Key Information
SWOT Analysis
13.3 Novartis International AG
Business Overview
Key Information
SWOT Analysis
13.4 Bayer HealthCare AG
Business Overview
Key Information
SWOT Analysis
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Over-the-counter Pharmaceuticals Market in the APAC Region 2012–2016 (US$ billion)
Exhibit 2: Over-the-counter Pharmaceuticals Market in the APAC Region Segmentation
Exhibit 3: Over-the-counter Pharmaceuticals Market in the APAC Region Segmentation 2012
Exhibit 4: Over-the-counter Pharmaceuticals Market in the APAC Region by Vendor Segmentation 2012
Exhibit 5: Business Segmentation of Johnson & Johnson
Exhibit 6: Business Segmentation of GlaxoSmithKline plc
Exhibit 7: Business Segmentation of Novartis International AG
Exhibit 8: Business Segmentation of Bayer HealthCare AG
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
